Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 9/20 | 0.66 |
| ▸ | ESR1 | P03372 | 8/20 | 0.66 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | CTSK | P43235 | 1/20 | 0.49 |
| ▸ | BACE1 | P56817 | 1/20 | 0.47 |
| ▸ | S100B | P04271 | 1/20 | 0.47 |
| ▸ | NOS3 | P29474 | 1/20 | 0.47 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.47 |
| ▸ | HTR3B | O95264 | 1/20 | 0.47 |
| ▸ | HTR3A | P46098 | 1/20 | 0.47 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.47 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.47 |
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6548684 | 0.92 | NOS3 (0.55) | ESR2ESR1CES2CES1BACE1 | |
| SCHEMBL19505630 | 0.88 | ESR1 (0.60) | ESR2ESR1CES2CES1NOS3 | |
| SCHEMBL24105688 | 0.86 | ESR2 (0.61) | ESR2ESR1CES2CES1NOS3 | |
| SCHEMBL30951898 | 0.84 | ESR2 (0.59) | ESR2ESR1CES2CES1NOS3 | |
| SCHEMBL15275550 | 0.84 | ESR2 (0.83) | ESR2ESR1CES2 | |
| SCHEMBL29022906 | 0.80 | ESR2 (1.00) | ESR2ESR1CES2 | |
| SCHEMBL17017259 | 0.80 | ADRA2A (0.44) | ESR2ESR1CES2CES1LTA4H | |
| SCHEMBL5024814 | 0.79 | CES2 (0.60) | ESR2CES2CES1LTA4H | |
| SCHEMBL28255793 | 0.79 | CES2 (0.60) | ESR2ESR1CES2CES1LTA4H | |
| SCHEMBL15717660 | 0.78 | ESR2 (0.71) | ESR2ESR1CES2CES1NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9533945-B2 | Ketene imine compound, polyester film, back sheet for solar cell module and solar cell module | FUJIFILM CORPORATION (JP) | 2017-01-03 | — | — | US | disclosed |
| US-20150232419-A1 | KETENE IMINE COMPOUND, POLYESTER FILM, BACK SHEET FOR SOLAR CELL MODULE AND SOLAR CELL MODULE | FUJIFILM CORPORATION (JP) | 2015-08-20 | — | — | US | disclosed |
| US-20150232419-A1 | KETENE IMINE COMPOUND, POLYESTER FILM, BACK SHEET FOR SOLAR CELL MODULE AND SOLAR CELL MODULE | FUJIFILM CORPORATION (JP) | 2015-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150232419-A1 | KETENE IMINE COMPOUND, POLYESTER FILM, BACK SHEET FOR SOLAR CELL MODULE AND SOLAR CELL MODULE | KRT18, PRRC2C, PKN1 | ESR2 1301/4885ESR1 647/4885CES2 1900/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.